MAD2L1 and myelodysplastic syndrome: Additionally, disruption of SAC protein function is widely reported in a variety of cancers and non-mutational alterations in SAC proteins, including MAD2, have specifically been reported in AML/MDS (11, 16, 17, 56–59).